Developing and Testing KOKU Bladder A Digital Program to Improve Bladder Health for Adults Aged 50 to 100
Led by University of Vic - Central University of Catalonia · Updated on 2025-03-30
120
Participants Needed
4
Research Sites
56 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating a digital health program designed to improve bladder health and manage urinary incontinence in adults aged 50 and over. This study involves co-creating a new module within the approved Keep-on-Keep-up KOKU app, developed with input from users, health professionals, and experts. The research includes a randomized controlled trial to test the programs feasibility and acceptability using behavior change techniques and addressing active and healthy aging policies.
The study is organized into several phases, starting with protocol preparation and expert consultations, followed by multiple focus groups in Lithuania, Spain, and the UK to co-create the app module. After development, a 12-week intervention will be conducted with at least 120 participants across three countries, randomly assigned to either the KOKU Bladder app group or a control group receiving recommendations for self-managing urinary symptoms. Both groups will be assessed using qualitative and quantitative methods.
Participants will engage in the trial for up to three years, during which their urinary incontinence symptoms, life impact, satisfaction with treatment, and bladder health will be regularly evaluated using questionnaires and tests such as the Incontinence Impact Questionnaire-7 and the International Prostate Symptom Score. Data collection includes thematic analysis of qualitative feedback and measurement of symptom severity and patient impressions. Safety and ethical considerations are integrated throughout, with plans for open communication and dissemination of results.
CONDITIONS
Brief Title
Keep On Keep Up Bladder Health: Co-creating and Testing a Self-management Technological Solution for Ageing Well
Research Team
J
Javier Jerez-Roig, Professor, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
University of Vic - Central University of Catalonia
Lead Sponsor
Hospital Universitari Santa Maria, Spain
Collaborating Sponsor
Who Can Participate
Age: 50Years - 100Years
All Genders
Eligibility Criteria
You may qualify if you...
Age 50 years or older
Self-reported urinary incontinence with at least one leakage per month
Ability to read and understand the national language
Access to a mobile phone or tablet
Signed informed consent provided
You will not qualify if you...
Presence of red-flag symptoms such as bleeding
Unstable health conditions
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or online)
Outpatient Treatment
Duration - 12 weeks
Participants receive either the KOKU Bladder digital health program or recommendations for self-managing urinary symptoms for 12 weeks.
Weekly visits or check-ins during the 12-week treatment period
Follow-up
Duration - Up to 3 years
After completing the treatment, participants are monitored to collect qualitative and quantitative results related to bladder health and urinary symptoms.
Periodic assessments over the following 3 years
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Developing and Testing KOKU Bladder A Digital Program to Improve Bladder Health for Adults Aged 50 to 100
Impact of Urinary Incontinence on Frailty and Geriatric Health in Adults 65 and Older
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Co-creating and testing a self-management digital solution for bladder health and urinary continence among people aged 50 and over: protocol for the international KOKU Bladder project.
Javier Jerez-Roig, Oscar Aguila-Gimeno, Marius Brazaitis...